Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 785 of 1,261

  1. US 8871904

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  2. US 8871794

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  3. US 8871905

    Modification of CXCR4 using engineered zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  4. US 8871774

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  5. US 8871766

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  6. US 8871447

    Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

    The Regents of the University of California · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  7. US 8871487

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  8. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  9. US 8871907

    Glycosylated immunoglobulin and immunoadhesin comprising the same

    KOREA PRIME PHARM CO., LTD. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  10. US 8871918

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  11. US 8871906

    Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  12. EP 2791134

    CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

    BIAL PORTELA & Cª S A [PT] · Granted Oct 22, 2014 · Expires Oct 17, 2034

    granted

  13. US 8865750

    Small molecule inhibitors of RGS proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  14. US 8865883

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  15. US 8865751

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  16. US 8865918

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  17. US 8865914

    Fluorescent probes for detection of copper

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  18. US 8865873

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  19. US 8865771

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  20. US 8865755

    Dual-acting antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  21. US 8865867

    Lectins and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  22. US 8865880

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  23. US 8865741

    Aminoindane compounds and use thereof in treating pain

    Asana BioSciences, LLC · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  24. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.